ASHER DANIEL 4

What Happened
Daniel Asher, a reported 10% owner of Ekso Bionics Holdings, Inc. (EKSO), made a series of open‑market purchases (transaction code P) between Feb 6 and Feb 13, 2026. He acquired a total of 102,029 shares for approximately $970,070. Individual trades ranged from small lots to larger purchases, with prices between $8.96 and $9.96 per share. These were purchases (inflows), not sales.

Key Details

• Transaction dates, sizes, prices and reported values:
  • 2026-02-06: 194 shares @ $9.86 = $1,912
  • 2026-02-09: 4,800 shares @ $9.96 = $47,820
  • 2026-02-10: 10,200 shares @ $9.92 = $101,225
  • 2026-02-11: 20,611 shares @ $9.69 = $199,770
  • 2026-02-12: 8,908 shares @ $9.18 = $81,815
  • 2026-02-12: 30,124 shares @ $9.69 = $291,841
  • 2026-02-13: 11,092 shares @ $9.14 = $101,413
  • 2026-02-13: 16,100 shares @ $8.96 = $144,274
• Total acquired: 102,029 shares for ~ $970,070.
• Shares owned after transaction: not specified in the filing.
• Footnotes of note:
  • F1: Asher is beneficial owner of DBA Trading, LLC and controls voting/dispositive power for those shares.
  • F2: Asher is grantor of Daniel Asher Descendants Trust and controls voting/dispositive power for those shares.
  • F3: None.
• Filing timeliness: Form 4 was filed on Feb 17, 2026 and covers trades from Feb 6–13, 2026. This appears later than the standard two-business-day Form 4 reporting window.

Context
These were open‑market purchases by a 10% owner (institutional/large shareholder status), not an option exercise or gift. Purchases are often viewed as a more informative insider signal than routine sales, but filings do not reveal the buyer’s motives. The beneficial ownership footnotes indicate the shares are held through entities/trusts controlled by Asher.